Sirtex warns on growth

Growth will slow in 2016 for this cancer therapy maker, but we aren't concerned.

The share price of radiotherapy maker Sirtex Medical fell 7% following an announcement that sales growth in the second half of the financial year would be below expectations. Management said dose sales for the year to June would be 15–17% higher than 2015, compared to prior guidance for growth of around 20%.


SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device

Verify your mobile number

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles